secwatch.observer — SEC 8-K summary
======================================

Issuer:     Milestone Pharmaceuticals Inc. (MIST)
CIK:        0001408443
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0001104659-23-115048
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Milestone to host webcast Nov 13 on etripamil Phase 2 AFib-RVR study results
----------------------------------------------------------------------------

- Webcast on Monday Nov 13, 2023 at 8:00 a.m. ET to discuss ReVeRA Phase 2 results of etripamil in AFib-RVR.
- Key opinion leaders A. John Camm, MD, and Sean Pokorney, MD, will join the webcast.
- Results presented as Featured Science at AHA Scientific Sessions 2023.
- Dial-in: (877) 870-4263 (domestic) or (412) 317-0790 (international).
- Webcast and slides accessible via News & Events section of Milestone's IR website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1408443/000110465923115048/0001104659-23-115048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1408443/000110465923115048/tm2330059d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-115048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer